Allan Camaisa

CEO, President and Chairman at Calidi Biotherapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Calidi Biotherapeutics Inc., 3 years.

Calidi Biotherapeutics Inc. Director · CEO and Chairman of the Board
3 years · Since 2023

Chief executive roles

Calidi Biotherapeutics Inc. · CEO, President and Chairman
Since September 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Dec 17, 2024 Calidi Biotherapeutics Inc. Open-market sale −10,000 $1.62 $16,200
Sep 26, 2024 Calidi Biotherapeutics Inc. Grant or award +70,155 $1.15 $80,678

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.